Page last updated: 2024-08-24

geranylgeraniol and Thyroid Neoplasms

geranylgeraniol has been researched along with Thyroid Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chang, TC; Lee, WS; Wang, CY; Zhong, WB	1

Other Studies

1 other study(ies) available for geranylgeraniol and Thyroid Neoplasms

Article	Year
Lovastatin induces apoptosis of anaplastic thyroid cancer cells via inhibition of protein geranylgeranylation and de novo protein synthesis. Endocrinology, 2003, Volume: 144, Issue:9 Topics: Anticholesteremic Agents; Apoptosis; Caspases; Cell Membrane; Cell Survival; Cytochrome c Group; Cytosol; Diterpenes; Humans; Intracellular Signaling Peptides and Proteins; Lovastatin; Protein Prenylation; Protein Serine-Threonine Kinases; Protein Synthesis Inhibitors; rho GTP-Binding Proteins; rho-Associated Kinases; rhoA GTP-Binding Protein; Thyroid Neoplasms; Tumor Cells, Cultured	2003

Article

Year

Lovastatin induces apoptosis of anaplastic thyroid cancer cells via inhibition of protein geranylgeranylation and de novo protein synthesis.

Endocrinology, 2003, Volume: 144, Issue:9

Topics: Anticholesteremic Agents; Apoptosis; Caspases; Cell Membrane; Cell Survival; Cytochrome c Group; Cytosol; Diterpenes; Humans; Intracellular Signaling Peptides and Proteins; Lovastatin; Protein Prenylation; Protein Serine-Threonine Kinases; Protein Synthesis Inhibitors; rho GTP-Binding Proteins; rho-Associated Kinases; rhoA GTP-Binding Protein; Thyroid Neoplasms; Tumor Cells, Cultured

2003